Monday, March 14, 2022

Invest in Psilly by Ei.Ventures’ Psychedelic SOLUTION to Mental Health

Invest today and help billions of people live better.
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
 
We have entered the final phase of our Pre-IPO Reg A+ offering. You can still make an investment by March 22, 2022. The minimum is only $498. Let's take plant powered therapies mainstream! Click here to learn more.
There has been a 20% increase in U.S antidepressant and anti-anxiety drugs since the beginning of COVID-19, according to a pharmaceutical study from ExpressScripts.

75% of people don't take their meds correctly, and more than half won't recover. 33% of adults are said to even be "treatment-resistant"  to certain pharmaceuticals!
So what's the answer?

Psilly by Ei.Ventures believes that nature got it right and is here to "flip the script".

We're developing novel platform delivery systems and formulations for delivering
natural psychedelic compounds for the treatment and prevention of chronic mental health disorders, improved cognitive function, and to democratize access to psychedelic therapies that minimize reliance on traditional pharmaceuticals.

How will we get there? And what are Ei.Ventures' solutions?
As of today, you have 8 1/2 days left to join our Reg A+ Pre-IPO, tap into this growing market, and help billions of people.

The three areas of product launch and acquisition that E.I. Ventures is focused on representing a combined estimated $100+ billion yearly marketplace.


Our strategy is three-fold:

Stage  01
Formulate novel psychedelic API, therapeutics, and delivery mechanisms for both commercialization and licensing.


Stage 02
Launch our proprietary functional mushroom formulations into the $250B nutraceutical market.

Stage 03
Develop out the Psychedelic Metaverse and mental wellness clinic using Web3 and Blockchain technology.

In the current landscape, certain companies are focused on creating synthetic psychedelic drugs. That's not us—and never will be.

We believe that synthetic treatments are ineffective, dangerous, and expensive.

That is why Ei.Ventures is focused on natural psychedelic therapies that create better and safer treatments that will meet FDA approval so people can get more effective help—faster.


Don't miss out on your last chance to invest and join Ei.Ventures' mission to help millions of people worldwide struggling with mental illness.

Join the 'farmaceutical' revolution today—and Invest Now.


Talk Soon,
David Nikzad







Legend: AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AT: https://www.sec.gov/Archives/edgar/data/1823182/000110465921153675/tm2136393-1_253g2.htm YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

Forward Looking Statements: Certain information set forth in this presentation, together with any supplements and any other information that may be furnished to prospective investors by the Company in connection therewith, contains "forward-looking statements" and "forward-looking information" within the meaning of applicable United States securities legislation (referred to herein as forward-looking statements). Except for statements of historical fact, certain information contained herein constitutes forward-looking statements which include but are not limited to statements related to activities, events or developments that Ei.Ventures expects or anticipates will or may occur in the future, statements related to the Company's business strategy objectives and goals, and management's assessment of future plans and operations which are based on current internal expectations, estimates, projections ,assumptions and beliefs, which may prove to be incorrect. Forward-looking statements can often be identified by the use of words such as "may", "will", "could", "would", "anticipate", 'believe", expect", "intend", "potential", "estimate", "budget","scheduled", "plans", "planned", "forecasts", "goals" and similar expressions or the negatives thereof. Forward-looking statements are neither historical facts nor assurances of future performance. Forward-looking statements are based on a number of factors and assumptions made by management and considered reasonable at the time such information is provided, and forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements.

 
EI.Ventures, 1215 S. Kihei Rd., Kihei, HI 96753, United States


No comments:

Page List

Blog Archive

Search This Blog

We're excited to have you on board

We'll be sending you the latest buy and sell ratings from Wall Street's top analysts, but first, this... ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...